153 related articles for article (PubMed ID: 27848185)
1. Pediatric intestinal Behçet disease complicated by myeloid malignancies.
Kanamitsu K; Shimada A; Nishiuchi R; Shigemura T; Nakazawa Y; Koike K; Kodama Y; Shinkoda Y; Kawano Y; Yasui K; Sasaki K; Kajiwara R; Tsukahara H; Manabe A
Int J Hematol; 2017 Mar; 105(3):377-382. PubMed ID: 27848185
[TBL] [Abstract][Full Text] [Related]
2. Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study.
Park JB; Han SJ; Lee SB; Kim DH; Cheon JH; Hwang SW; Ye BD; Yang SK; Park SJ; Park SH;
Yonsei Med J; 2024 May; 65(5):265-275. PubMed ID: 38653565
[TBL] [Abstract][Full Text] [Related]
3. Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behcet disease and antithrombin III deficiency.
Ando S; Maemori M; Sakai H; Ando S; Shiraishi H; Sakai K; Ruhnke GW
Cancer Genet Cytogenet; 2005 Oct; 162(2):172-5. PubMed ID: 16213367
[TBL] [Abstract][Full Text] [Related]
4. The association of Behçet's disease with myelodysplastic syndrome in Japan: a review of the literature.
Tada Y; Koarada S; Haruta Y; Mitamura M; Ohta A; Nagasawa K
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S115-9. PubMed ID: 17067441
[TBL] [Abstract][Full Text] [Related]
5. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet disease.
Yamato K
Int J Hematol; 2003 Jan; 77(1):82-5. PubMed ID: 12568304
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature.
Soysal T; Salihoğlu A; Esatoğlu SN; Gültürk E; Eşkazan AE; Hatemi G; Hatemi I; Öngören Aydın Ş; Erzin YZ; Başlar Z; Tüzüner N; Ferhanoğlu B; Çelik AF
Rheumatology (Oxford); 2014 Jun; 53(6):1136-41. PubMed ID: 24505123
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.
Tanaka H; Shimizu N; Tougasaki E; Kawajiri C; Hashimoto S; Takeda Y; Sakai S; Takeuchi M; Ohwada C; Sakaida E; Takagi T; Nakaseko C
Int J Hematol; 2013 Apr; 97(4):520-4. PubMed ID: 23519573
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report.
Asano T; Sato S; Furuya MY; Takahashi H; Shichishima-Nakamura A; Ohkawara H; Fujiwara T; Gunji N; Hashimoto C; Momma T; Saito M; Nakano H; Watanabe G; Temmoku J; Fujita Y; Matsuoka N; Kobayashi H; Watanabe H; Mouri M; Mashiyama F; Sakuma H; Ohira H; Mori M; Ikezoe T; Migita K
Medicine (Baltimore); 2019 Nov; 98(46):e17979. PubMed ID: 31725663
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
11. Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature.
Toyonaga T; Nakase H; Matsuura M; Minami N; Yamada S; Honzawa Y; Hukata N; Yoshino T; Chiba T; Okazaki K
Digestion; 2013; 88(4):217-21. PubMed ID: 24247154
[TBL] [Abstract][Full Text] [Related]
12. Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.
Scott BL; Storer BE; Greene JE; Hackman RC; Appelbaum FR; Deeg HJ
Biol Blood Marrow Transplant; 2007 Mar; 13(3):345-54. PubMed ID: 17317588
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.
Onaka T; Nakano K; Uemoto Y; Miyakawa N; Otsuka Y; Ogura-Kato A; Iwai F; Tanaka Y; Yonezawa A
Mod Rheumatol Case Rep; 2022 Jun; 6(2):273-277. PubMed ID: 35365826
[TBL] [Abstract][Full Text] [Related]
14. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet's disease by up-front cord blood transplantation.
Nonami A; Takenaka K; Sumida C; Aizawa K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Intern Med; 2007; 46(20):1753-6. PubMed ID: 17938534
[TBL] [Abstract][Full Text] [Related]
16. Myeloid sarcoma arising at the uterine cervix in a patient with intestinal Behçet's disease and concurrent myelodysplastic syndrome: A case report.
Choi HY; Pak MG; Park JW
Medicine (Baltimore); 2022 Oct; 101(43):e31559. PubMed ID: 36316914
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation.
Kook MH; Yhim HY; Lee NR; Song EK; Kim HS; Yim CY; Kwak JY
Korean J Intern Med; 2014 Jan; 29(1):123-5. PubMed ID: 24574844
[No Abstract] [Full Text] [Related]
18. Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
Gao L; Gao L; Gong Y; Zhang C; Chen XH; Zhang X
Leuk Res; 2013 Nov; 37(11):1482-7. PubMed ID: 24054720
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8.
Kawabata H; Sawaki T; Kawanami T; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Ogawa N; Hirose Y; Ozaki K; Shimanaka K; Takase S; Ueno H; Umehara H
Intern Med; 2006; 45(22):1309-14. PubMed ID: 17170506
[TBL] [Abstract][Full Text] [Related]
20. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
